Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein - PubMed (original) (raw)
. 2003 Feb 14;278(7):5255-63.
doi: 10.1074/jbc.M204591200. Epub 2002 Nov 12.
Affiliations
- PMID: 12431996
- DOI: 10.1074/jbc.M204591200
Free article
Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein
Yan Xia et al. J Biol Chem. 2003.
Free article
Abstract
The breast and ovarian cancer-specific tumor suppressor RING finger protein BRCA1 has been identified as an E3 ubiquitin (Ub) ligase through in vitro studies, which demonstrated that its RING finger domain can autoubiquitylate and monoubiquitylate histone H2A when supplied with Ub, E1, and UBC4 (E2). Here we report that the E3 ligase activity of the N-terminal 110 amino acid residues of BRCA1, which encodes a stable domain containing the RING finger, as well as that of the full-length BRCA1, was significantly enhanced by the BARD1 protein (residues 8-142), whose RING finger domain itself lacked Ub ligase activity in vitro. The results of mutagenesis studies indicate that the enhancement of BRCA1 E3 ligase activity by BARD1 depends on direct interaction between the two proteins. Using K48A and K63A Ub mutants, we found that BARD1 stimulated the formation of both Lys(48)- and Lys(63)-linked poly-Ub chains. However, the enhancement of BRCA1 autoubiquitylation by BARD1 mostly resulted in poly-Ub chains linked through Lys(63), which could potentially activate biological pathways other than BRCA1 degradation. We also found that co-expression of BRCA1 and BARD1 in living cells increased the abundance and stability of both proteins and that this depended on their ability to heterodimerize.
Similar articles
- The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T. Hashizume R, et al. J Biol Chem. 2001 May 4;276(18):14537-40. doi: 10.1074/jbc.C000881200. Epub 2001 Mar 6. J Biol Chem. 2001. PMID: 11278247 - Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.
Brzovic PS, Keeffe JR, Nishikawa H, Miyamoto K, Fox D 3rd, Fukuda M, Ohta T, Klevit R. Brzovic PS, et al. Proc Natl Acad Sci U S A. 2003 May 13;100(10):5646-51. doi: 10.1073/pnas.0836054100. Epub 2003 May 5. Proc Natl Acad Sci U S A. 2003. PMID: 12732733 Free PMC article. - Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.
Mallery DL, Vandenberg CJ, Hiom K. Mallery DL, et al. EMBO J. 2002 Dec 16;21(24):6755-62. doi: 10.1093/emboj/cdf691. EMBO J. 2002. PMID: 12485996 Free PMC article. - The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus SR, Stewart MD, Klevit RE. Witus SR, et al. Biochem J. 2021 Sep 30;478(18):3467-3483. doi: 10.1042/BCJ20200864. Biochem J. 2021. PMID: 34591954 Free PMC article. Review. - The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
Baer R, Ludwig T. Baer R, et al. Curr Opin Genet Dev. 2002 Feb;12(1):86-91. doi: 10.1016/s0959-437x(01)00269-6. Curr Opin Genet Dev. 2002. PMID: 11790560 Review.
Cited by
- BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer.
Ismail T, Alzneika S, Riguene E, Al-Maraghi S, Alabdulrazzak A, Al-Khal N, Fetais S, Thanassoulas A, AlFarsi H, Nomikos M. Ismail T, et al. Pharmaceuticals (Basel). 2024 Mar 4;17(3):333. doi: 10.3390/ph17030333. Pharmaceuticals (Basel). 2024. PMID: 38543119 Free PMC article. Review. - Functional Analyses of Rare Germline Missense BRCA1 Variants Located within and outside Protein Domains with Known Functions.
Hovland HN, Mchaina EK, Høberg-Vetti H, Ariansen SL, Sjursen W, Van Ghelue M, Haukanes BI, Knappskog PM, Aukrust I, Ognedal E. Hovland HN, et al. Genes (Basel). 2023 Jan 19;14(2):262. doi: 10.3390/genes14020262. Genes (Basel). 2023. PMID: 36833189 Free PMC article. - Differential requirement for BRCA1-BARD1 E3 ubiquitin ligase activity in DNA damage repair and meiosis in the Caenorhabditis elegans germ line.
Li Q, Kaur A, Okada K, McKenney RJ, Engebrecht J. Li Q, et al. PLoS Genet. 2023 Jan 30;19(1):e1010457. doi: 10.1371/journal.pgen.1010457. eCollection 2023 Jan. PLoS Genet. 2023. PMID: 36716349 Free PMC article. - BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1.
Hromas R, Srinivasan G, Yang M, Jaiswal A, Totterdale TA, Phillips L, Kirby A, Khodayari N, Brantley M, Williamson EA, Kong KY. Hromas R, et al. iScience. 2022 Nov 19;25(12):105626. doi: 10.1016/j.isci.2022.105626. eCollection 2022 Dec 22. iScience. 2022. PMID: 36471805 Free PMC article. - Computed cancer interactome explains the effects of somatic mutations in cancers.
Zhang J, Pei J, Durham J, Bos T, Cong Q. Zhang J, et al. Protein Sci. 2022 Dec;31(12):e4479. doi: 10.1002/pro.4479. Protein Sci. 2022. PMID: 36261849 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous